Monday, 24 July 2017

Vaccines News

  • FDA approves Flucelvax, a cell-culture vaccine against seasonal influenza

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012

    Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-culture-derived vaccine, for individuals 18 years of age and older. Develo...Read more

  • Takeda acquires LigoCyte Pharmaceuticals at $60 mn

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012

    Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious initiative aims to deliver new treatment ...Read more

  • FDA approves GSK's combo meingitis vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012

    Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine). Men...Read more

  • Biodiem gets US patent allowance for antifungal therapy

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowance of a new US divisional patent from US Patent and Trademark Office, ...Read more

  • Arterial Remodeling Technologies receives regulatory approval

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012

      Australian vaccine development company BioDiem Ltd has announced that it has begun research collaboration with France-based VIVALIS, a biopharmaceutical company with expertise in vaccin...Read more

  • 'China's H7N9 outbreak an epidemic'

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 17 Mar, 2014

    Singapore: While experts and health ministries in various Chinese provinces have declared the on-going second wave of H7N9 in the country as more destructive than the first one in early 201...Read more

  • MR vaccine drive for all

    Vaccines |  News | 0 Comment | 13 Apr, 2017

    To quell the rumours around the measles-rubella vaccine, UNICEF has reached out to Islamic civil society organisations, religious leaders and academia to create trust and address myths arou...Read more

  • Globally Zika Virus vaccines market expected to reach $18,697 mn by 2022

    Vaccines |  News | 0 Comment | 04 Jan, 2017

    A new report published by Allied Market Research, titled, “Potential Market for Zika Virus Vaccines: Global Opportunity Analysis and Industry Forecast, 2017–2022”, project...Read more

  • CEPI board meeting with a focus on identifying disease priorities and future strategy

    Vaccines |  News | By Raj Gunashekar | 0 Comment | 19 Dec, 2016

    The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI) which is a new global alliance among governments, industries, acad...Read more

  • Sequenom files patent infringement lawsuit in Australia

    Vaccines |  Opinion | By Raj Gunashekar | 0 Comment | 18 Jun, 2016

    Singapore: If reports are to be believed French drug giant Sanofi is all set to launch 20 new drugs in Japan by 2020. In a recently held press meet the company's CEO Mr Jacques Nathan said ...Read more

Survey Box

Is value- based patient healthcare system more effective in Asian countries?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls